Thermo Fisher Scientific Inc. (NYSE:TMO) is expanding its partnership with Sanofi to support drug product manufacturing in the US. The company will acquire Sanofi’s manufacturing site in Ridgefield, New Jersey, to produce and develop therapies. Thermo Fisher plans to use the site to meet increasing demand from biotech and pharma customers. The Ridgefield site includes a sterile fill-finish and packaging facility with over 200 employees. Thermo Fisher provides analytical instruments, reagents, equipment, software, and services for analysis, research, diagnostics, and discovery. The company operates through various segments, including Analytical Instruments and Life Sciences Solutions.

Read more at Yahoo Finance: Thermo Fisher Scientific (TMO) Announces Strategic Partnership Expansion With Sanofi